In addition to speed and reliability, the test is further characterized by a pretraetment process that helps protect laboratory staff from the virus. Such testing could be deployed at on-site collection centers for hospital staff, patients and visitors, remote collection facilities for large scale testing of local populations or in dedicated, pop-up labs at airports or universities. It also offers a leading time-to-result for lab-based antigen tests, making it an ideal tool to test large quantities of patient samples quickly.

The antigen test detects the nucleocapsid antigen and has been designed with five monoclonal antibodies with the objective to maximize its sensitivity to both current and future SARS-CoV-2 variants. The test has been submitted to the FDA for Emergency Use Authorization. Siemens Healthineers announced today the company’s laboratory-based SARS-CoV-2 Antigen Assay (CoV2Ag) 1 obtained CE Mark and is now offered for the Atellica ® Solution and ADVIA Centaur® analyzers, widely available in laboratories worldwide. Please note, there is a no returns policy on this product.SARS-CoV-2 Antigen Assay offers testing for current Covid-19 infection worldwide on a widely available installed base of automated immunoassay analyzers. *The test result of rapid tests that are on the European Commission’s list of COVID-19 antigen rapid tests is recognised in all member states of the EU. 1 pack with 20 antigen tests and accessories.Please note that the test cannot be returned or exchanged.For use by healthcare professionals only.Specificity (nasal swab): 100% Easy to use.Specificity (nasopharyngeal swab): 99.42.Relative sensitivity (nasal swab): 97.25%.Relative sensitivity (nasopharyngeal swab): 98.32%.Test material: Nasopharyngeal swabs and nasal swabs.On the European Commission’s common list for COVID-19 antigen rapid tests*.For the diagnosis of acute SARS-CoV-2 infections.On the list of the BfArM (Federal Institute for Drugs and Medical Devices) and the French Ministry of Health.Evaluated by the Paul Ehrlich Institute.Rapid and reliable detection of COVID-19 antigens.Siemens Clinitest Rapid COVID-19 Antigen Test.It provides reliable test results within only 15 minutes thanks to its high sensitivity and specificity. The antigen rapid test is listed by the Federal Institute for Drugs and Medical Devices( BfArM) and has been evalutated by the Paul Ehrlich Institute, a German federal agency and medical regulatory body. The Siemens Clinitest Rapid COVID-19 antigen test is for the rapid detection of COVID-19 antigens in nasal or nasopharyngeal swabs for reliable point-of-care testing. Ambulatory Blood Pressure Monitor - ABPMĭescription Siemens Clinitest Rapid COVID-19 Antigen Test.

Siemens web based test